VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS30008495 | HIV | ENSG00000121879.6 | protein_coding | PIK3CA | Yes | No | 5290 | P42336 Q4LE51 |
TVIS30059013 | HIV | ENSG00000121879.6 | protein_coding | PIK3CA | Yes | No | 5290 | P42336 Q4LE51 |
TVIS30059014 | HIV | ENSG00000121879.6 | protein_coding | PIK3CA | Yes | No | 5290 | P42336 Q4LE51 |
TVIS30059015 | HIV | ENSG00000121879.6 | protein_coding | PIK3CA | Yes | No | 5290 | P42336 Q4LE51 |
TVIS30059016 | HIV | ENSG00000121879.6 | protein_coding | PIK3CA | Yes | No | 5290 | P42336 Q4LE51 |
TVIS30059017 | HIV | ENSG00000121879.6 | protein_coding | PIK3CA | Yes | No | 5290 | P42336 Q4LE51 |
TVIS30059018 | HIV | ENSG00000121879.6 | protein_coding | PIK3CA | Yes | No | 5290 | P42336 Q4LE51 |
TVIS30059019 | HIV | ENSG00000121879.6 | protein_coding | PIK3CA | Yes | No | 5290 | P42336 Q4LE51 |
TVIS30059020 | HIV | ENSG00000121879.6 | protein_coding | PIK3CA | Yes | No | 5290 | P42336 Q4LE51 |
TVIS30059021 | HIV | ENSG00000121879.6 | protein_coding | PIK3CA | Yes | No | 5290 | P42336 Q4LE51 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | PIK3CA |
---|---|
DrugBank ID | DB12015 |
Drug Name | Alpelisib |
Target ID | BE0002379 |
UniProt ID | P42336 |
Regulation Type | inhibitor |
PubMed IDs | 28852212; 29109464 |
Citations | Chen IC, Hsiao LP, Huang IW, Yu HC, Yeh LC, Lin CH, Wei-Wu Chen T, Cheng AL, Lu YS: Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen. Sci Rep. 2017 Aug 29;7(1):9842. doi: 10.1038/s41598-017-10555-z.@@Yang X, Zhang X, Huang M, Song K, Li X, Huang M, Meng L, Zhang J: New Insights into PI3K Inhibitor Design using X-ray Structures of PI3Kalpha Complexed with a Potent Lead Compound. Sci Rep. 2017 Nov 6;7(1):14572. doi: 10.1038/s41598-017-15260-5. |
Groups | Approved; Investigational |
Direct Classification | Proline and derivatives |
SMILES | CC1=C(SC(NC(=O)N2CCC[C@H]2C(N)=O)=N1)C1=CC(=NC=C1)C(C)(C)C(F)(F)F |
Pathways | |
PharmGKB | |
ChEMBL | CHEMBL2396661 |